SAGE THERAPEUTICS INC shareholders Q2 2023

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 224 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

SAGE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Engineers Gate Manager LP 19,340$909,3670.03%
PICTET ASSET MANAGEMENT SA 598,918$28,161,1240.03%
ClariVest Asset Management LLC 14,078$6620.03%
PRELUDE CAPITAL MANAGEMENT, LLC 10,000$470,2000.03%
E Fund Management Co., Ltd. 7,457$3510.03%
PRELUDE CAPITAL MANAGEMENT, LLC 9,017$423,9790.03%
DEUTSCHE BANK AG\ 1,034,741$48,653,5220.03%
DIMENSIONAL FUND ADVISORS LP 1,716,268$80,699,2920.03%
Caption Management, LLC 30,000$1,410,6000.02%
D. E. Shaw & Co., Inc. 451,272$21,218,8100.02%
Connor, Clark & Lunn Investment Management Ltd. 93,329$4,388,3300.02%
FIDUCIARY TRUST CO 25,915$1,218,5230.02%
VIRGINIA RETIREMENT SYSTEMS ET AL 41,100$1,932,5220.02%
ALPS ADVISORS INC 43,930$2,065,5890.02%
MARTINGALE ASSET MANAGEMENT L P 16,914$795,2970.02%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 593,938$27,926,9650.02%
OPPENHEIMER & CO INC 14,813$696,5070.01%
Aquatic Capital Management LLC 5,600$2630.01%
Princeton Global Asset Management LLC 1,000$47,0200.01%
AMERIPRISE FINANCIAL INC 890,043$41,849,8210.01%
External links

This page lists SAGE THERAPEUTICS INC's shareholders in Q2 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.